Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor

Atherosclerosis

Volumn 224, Issue 2, 2012, Pages 332-339

  Chen, Jing ^a   Zhang, Jing ^a   Xu, Lin ^a   Xu, Changwu ^a   Chen, Sisi ^a   Yang, Jian ^a   Jiang, Hong ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

High mobility group box 1 protein; Inflammation; Neointima formation; Oxidative stress; Phenotype

Indexed keywords

ANGIOTENSIN II; GLYCYRRHIZIC ACID; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NOTCH RECEPTOR; SYNAPTOPHYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CAROTID ARTERY INJURY; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG TARGETING; HYPERPLASIA; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; MIGRATION INHIBITION; MOLECULAR BIOLOGY; NEOINTIMA; NEOINTIMAL HYPERPLASIA; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; THORACIC AORTA;

ANGIOTENSIN II; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CARDIOVASCULAR AGENTS; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCYRRHIZIC ACID; HMGB1 PROTEIN; HYPERPLASIA; INFLAMMATION MEDIATORS; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; NF-KAPPA B; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENOTYPE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84866560448     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.07.020     Document Type: Article

References (37)

1. Clowes A.W., Clowes M.M., Fingerle J., Reidy M.A. Kinetics of cellular proliferation after arterial injury. V. Role of acute distension in the induction of smooth muscle proliferation. Lab Invest 1989, 60:360-364.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
3. Costa M.A., Simon D.I. Molecular basis of restenosis and drug-eluting stents. Circulation 2005, 111:2257-2273.
4. Ashley E.A., Ferrara R., King J.Y., et al. Network analysis of human in-stent restenosis. Circulation 2006, 114:2644-2654.
5. Goodfriend T.L., Elliott M.E., Catt K.J. Angiotensin receptors and their antagonists. N Engl J Med 1996, 334:1649-1654.
6. Kaplan-Albuquerque N., Bogaert Y.E., Van Putten V., Weiser-Evans M.C., Nemenoff R.A. Patterns of gene expression differentially regulated by platelet-derived growth factor and hypertrophic stimuli in vascular smooth muscle cells: markers for phenotypic modulation and response to injury. J Biol Chem 2005, 280:19966-19976.
7. Han M., Wen J.K., Zheng B., Cheng Y., Zhang C. Serum deprivation results in redifferentiation of human umbilical vascular smooth muscle cells. Am J Physiol Cell Physiol 2006, 291:C50-C58.
8. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 1999, 19:5237-5246.
9. Fiuza C., Bustin M., Talwar S., et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003, 101:2652-2660.
10. Andersson U., Wang H., Palmblad K., et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000, 192:565-570.
11. Ulloa L., Messmer D. High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev 2006, 17:189-201.
12. Fang W.H., Yao Y.M., Shi Z.G., et al. The significance of changes in high mobility group-1 protein mRNA expression in rats after thermal injury. Shock 2002, 17:329-333.
13. Abraham E., Arcaroli J., Carmody A., Wang H., Tracey K.J. HMG-1 as a mediator of acute lung inflammation. J Immunol 2000, 165:2950-2954.
14. Tsung A., Sahai R., Tanaka H., et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 2005, 201:1135-1143.
15. Xu H., Yao Y., Su Z., et al. Endogenous HMGB1 contributes to ischemia-reperfusion-induced myocardial apoptosis by potentiating the effect of TNF-α/JNK. Am J Physiol Heart Circ Physiol 2011, 300:H913-H921.
16. Kalinina N., Agrotis A., Antropova Y., et al. Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines. Arterioscler Thromb Vasc Biol 2004, 24:2320-2325.
17. Chin M.T., Pellacani A., Hsieh C.M., et al. Induction of high mobility group I architectural transcription factors in proliferating vascular smooth muscle in vivo and in vitro. J Mol Cell Cardiol 1999, 31:2199-2205.
18. Tokunou T., Shibata R., Kai H., et al. Apoptosis induced by inhibition of cyclic AMP response element-binding protein in vascular smooth muscle cells. Circulation 2003, 108:1246-1252.
19. Chen J., Jiang H., Xu L., et al. Dysregulation of CREB binding protein triggers thrombin-induced proliferation of vascular smooth muscle cells. Mol Cell Biochem 2008, 315(1-2):123-130.
20. Li L., Frei B. Iron chelation inhibits NF-kappaB-mediated adhesion molecule expression by inhibiting p22(phox) protein expression and NADPH oxidase activity. Arterioscler Thromb Vasc Biol 2006, 26:2638-2643.
21. Owens G.K., Kumar M.S., Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004, 84:767-801.
22. Wang L., Zheng J., Du Y., et al. Cartilage oligomeric matrix protein maintains the contractile phenotype of vascular smooth muscle cells by interacting with alpha(7)beta(1) integrin. Circ Res 2010, 106:514-525.
23. Morrow D., Guha S., Sweeney C., et al. Notch and vascular smooth muscle cell phenotype. Circ Res 2008, 103:1370-1382.
24. Paravicini T.M., Touyz R.M. Redox signaling in hypertension. Cardiovasc Res 2006, 71:247-258.
25. Zafari A.M., Ushio-Fukai M., Akers M., et al. Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension 1998, 32:488-495.
26. Yaghini F.A., Song C.Y., Lavrentyev E.N., et al. Angiotensin II-induced vascular smooth muscle cell migration and growth are mediated by cytochrome P450 1B1-dependent superoxide generation. Hypertension 2010, 55:1461-1467.
27. Mueller C., Baudler S., Welzel H., Böhm M., Nickenig G. Identification of a novel redox-sensitive gene, Id3, which mediates angiotensin II-induced cell growth. Circulation 2002, 105:2423-2428.
28. Tang D., Kang R., Xiao W., et al. Nuclear heat shock protein 72 as a negative regulator of oxidative stress (hydrogen peroxide)-induced HMGB1 cytoplasmic translocation and release. J Immunol 2007, 178:7376-7384.
29. Tsung A., Klune J.R., Zhang X., et al. HMGB1 release induced by liver ischemia involves toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med 2007, 204:2913-2923.
30. Soro-Paavonen A., Watson A.M., Li J., et al. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes 2008, 57:2461-2469.
31. Ebrahimian T., Li M.W., Lemarié C.A., et al. Mitogen-activated protein kinase-activated protein kinase 2 in angiotensin II-induced inflammation and hypertension: regulation of oxidative stress. Hypertension 2011, 57:245-254.
32. Alexis J.D., Wang N., Che W., et al. Bcr kinase activation by angiotensin II inhibits peroxisome-proliferator-activated receptor gamma transcriptional activity in vascular smooth muscle cells. Circ Res 2009, 104:69-78.
33. Kitahara T., Takeishi Y., Harada M., et al. High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. Cardiovasc Res 2008, 80:40-46.
34. Yang H., Ochani M., Li J., et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A 2004, 101:296-301.
35. Youn J.H., Oh Y.J., Kim E.S., Choi J.E., Shin J.S. High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes. J Immunol 2008, 180:5067-5074.
36. Qin Y.H., Dai S.M., Tang G.S., et al. HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products. J Immunol 2009, 183:6244-6250.
37. Degryse B., Bonaldi T., Scaffidi P., et al. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol 2001, 152:1197-1206.